Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Revolution Medicines Inc. Common Stock (RVMD) vs Solaredge Technologies Inc (SEDG) Price & Performance

Revolution Medicines Inc. Common StockTrade
Solaredge Technologies IncTrade

Price performance (Past 24H)

Key statistics

Revolution Medicines Inc. Common Stock vs Solaredge Technologies Inc — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B), while Solaredge Technologies Inc trades at $32.21 (market cap $2.00B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 20.2× Solaredge Technologies Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Solaredge Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Solaredge Technologies Inc for 34 Days on average.

RVMDSEDG
Market Cap
$40.32B$2.00B
Volume
4,855,7342,739,860
Sector
HealthEnergy
52-Week High
$221.15$78.51
52-Week Low
$47.50$28.47
Typical Hold Time
0 Days34 Days
Enterprise Value
$37.02B$1.86B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Revolution Medicines Inc. Common Stock

No Aura AI signal available yet.

Solaredge Technologies Inc

SolarEdge Technologies (SEDG) trades at $32.47, down 2.08% amid bearish technical signals and ongoing financial challenges. The company reported a net loss of $405 million in 2025 with negative profit margins, though revenue showed some recovery to $1.18 billion. Recent news highlights multiple law firm investigations into investor claims while the company pursues AI data center expansion opportunities.

The outlook remains challenging with significant execution risks and negative profitability, though analyst consensus suggests modest upside potential to the $37.75 price target. Key risks include ongoing legal scrutiny, competitive pressures in solar markets, and the company's ability to achieve its ambitious 2029 revenue target of $2.4 billion.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RVMD
100% Buy0% Sell
Avg holding period · 0 Days
SEDG
42% Buy58% Sell
Avg holding period · 34 Days

Top news

Latest headlines on both assets

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →

About Solaredge Technologies Inc

SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.

Read more on SEDG →